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Intrauterine growth restricted (IUGR) born individuals are at a higher risk for 
developing obesity and associated co-morbidities in adulthood.  An underlying 
component of these morbidities is adipose dysfunction, with the accumulation of visceral 
adipose tissue (VAT) in conjunction with an increased expression of peroxisome 
proliferator activated receptor gamma PPARγ, a proadipogenic factor.  Interestingly, in 
hepatic tissue of the adolescent IUGR female, PPARγ expression displays a decreasing 
trend.  PPARγ’s actions may be mediated by set domain containing histone 
methyltransferase Setd8 an epigenetic modification enzyme, and direct transcriptional 
target of PPARγ.  In this study, we hypothesize that IUGR will affect mRNA and protein 
levels of Setd8 in a gender and tissue specific manner in visceral adipose tissue (VAT), 
subcutaneous adipose tissue (SAT), and hepatic depots before the onset of metabolic 
disease in postnatal day 21 rats.  Uteroplacental insufficiency (UPI) induced IUGR day 
21 adipose (SAT and VAT), and hepatic tissue was compared to control tissue using real 
time RT PCR for mRNA and western blotting for protein levels of Setd8.  IUGR 
increased Setd8 protein levels in visceral adipose tissue of males of and decreased Setd8 
protein levels hepatic tissue of females.  IUGR did not have a significant effect on SAT 
mRNA and protein levels.  This study demonstrates that IUGR alters Setd8 expression in 
day 21 rat in a gender and tissue specific manner, consistent with previously observed 
changes in PPARγ expression, before the onset of metabolic disease and obesity.  We
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speculate that IUGR alters epigenetic gene regulation in adipose and liver, PPARγ and its 
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INTRODUCTION 
Intrauterine Growth Restriction 
Intrauterine growth restriction (IUGR) affects 5-12% of infants in developed 
nations every year, (1) and is mainly caused by uteroplacental insufficiency (UPI) (2).  
Preeclampsia is the leading cause of UPI induced IUGR in humans (3).  UPI refers to the 
reduced amount of blood flow from the uterus to the placenta, resulting in decreased 
nutrients and oxygen to the fetus.  Given these conditions, the fetus fails to achieve its 
genetic growth potential (4, 5).  During critical periods of prenatal development, poor 
nutrition and other environmental factors induce epigenetic variation and gene expression 
changes leading to permanent changes in metabolism and chronic disease susceptibility 
(6).  Evidence in human and animal studies (7) shows that infants who are born IUGR are 
at a higher risk for heart disease, hypertension, type 2 diabetes, abnormal glucose-insulin 
metabolism and increased serum cholesterol levels (6).  IUGR infants have 
physiologically impaired adipose tissue regulation, which is accompanied by adult onset 
metabolic disease, insulin resistance, poor fatty acid utilization, hepatic steatosis and  
obesity in a gender specific manner (8).   
Adipocyte Dysfunction Linked to Metabolic Disease 
In addition to its ability to store triglycerides adipose tissue is a complex, active 
endocrine organ, capable of sending and receiving signals in order to modulate energy  
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 expenditure, reproduction, and sensitivity to insulin (9).  Interestingly, IUGR adipose 
tissue regulation seems to be physiologically dysregulated before the onset of obesity and 
metabolic disease (10).  For example, IUGR infants are born smaller, buy they experience 
accelerated weight gain and obtain more adipose tissue during childhood when compared 
to infants who achieve full genetic growth potential at birth (2, 11).  In addition, IUGR 
favors the accumulation of Visceral Adipose Tissue (VAT) rather that Subcutaneous 
Adipose Tissue (SAT) in a gender specific manner.  MRI scans of IUGR male rats show 
an increased amount of VAT and VAT per gram body weight on postnatal day 21, 
indicating increased lipid storage (12).  VAT and SAT have different functions and this 
differences in distribution and depots effect gene regulation and ultimately the phenotype.  
The increase amount of VAT is metabolically detrimental.  This shift towards VAT is 
consistent with adult onset metabolic disease and altered adipose function.  Further, 
increased VAT has been reported in obesity and high fat diet models (13) in male animals  
(14).   
PPARγ 
The increase in VAT in male IUGR rats is associated with an increased 
expression of peroxisome proliferator activated receptor gamma (PPARγ).  PPARγ is part 
of the PPAR nuclear receptor super family, and is a transcription factor that binds to and 
alters the transcription of a number of genes involved in cellular metabolism, 
adipogenesis, and lipid storage (15).  The PPARγ gene translates two protein isoforms: 
PPARγ1, which is the widely expressed including in the liver, and PPARγ2, which is 
specific to adipose, liver and lung tissues.  This distinct tissue specificity is attained via 
alternative splicing, and promoter usage (16).  PPARγ2 transcriptional activity is ligand 
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dependent.  Docosahexanoic acid (DHA), fatty acid derivatives and the insulin 
sensitizing drugs are PPARγ2 ligands.  They cause a conformational change affecting 
transcription of PPARγ2 and its target genes, ultimately improving insulin sensitivity.  
PPARγ2 isoform is a vital regulator of adipocyte differentiation, maintenance, and 
survival (17).  In rat IUGR models where IUGR is induced by either 50% maternal food 
restriction during gestation or UPI, it has been shown that PPARγ2 is up-regulated in 
VAT of male IUGR rats (12, 18).  In preliminary studies, IUGR significantly increased 
PPARγ2 mRNA expression in liver of day 21 male rats, promoting lipid deposition and 
storage and ultimately resulting in increased hepatic steatosis.  Interestingly, PPARγ1 
mRNA in the liver is decreased at postnatal day 0, and postnatal day 21 in IUGR female 
animals.   
A further role of PPARγ involves the transcriptional regulation of epigenetic 
modifying enzymes.  Epigenetics refers to heritable changes in gene expression potential 
that are not caused by changes in DNA.  A mechanism of epigenetic gene regulation is 
histone modifications.  Chromatin is made up of DNA associated with histone proteins.   
Chromatin conformation is regulated differently in different tissues by number of 
modifications to residues in the tails of histone proteins.  Epigenetic modifying enzymes 
place epigenetic markers on the residues of histone tail proteins that are associated with a 
particular gene.  Some of these markers include acetylation, methylation, 
phosphorylation, ubiquitination, and sumoylation (19).  The mark dictates the interactions 
of the gene with all the transcription factors.  Setd8, set domain containing histone 
methyltransferase, has a PPAR response element in its promoter region and it is a bona 
fide transcription factor of PPARγ.  Several lines of evidence indicate that Setd8 is 352 
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amino acids long and its molecular mass is calculated at about 45 kDa (20).  Although the 
underlying mechanism of activity of this methyltransferase remains unknown, its specific 
role in monomethylating histone H4 Lysine 20 (H4K20me1) is well documented (21).  In 
adipose tissue, during differentiation PPARγ up regulates the expression of Setd8, which 
in turn increases transcription of the PPARγ gene and its targets such as fatty acid binding 
protein 4 (FABP4) and cluster of differentiation 36 (CD36) through H4K20me1 (15).  
Further, PPARγ binds to the PPARy2 promoter, inducing histone modification and 
ultimately increasing its transcription.  This proposed mechanism links PPARγ and Setd8 
transcription with epigenetic chromatin modulation through H4K20me1 during 
adipogenesis through a feedback loop (15).   
Despite the known connection of IUGR and PPARγ expression in a gender and 
tissue specific manner, the effect of IUGR Setd8 expression in adipose and hepatic tissue 
is unknown.  Therefore the purpose of this study is to assess the effect of IUGR on the 
PPARγ target gene Setd8 in the adipose and hepatic tissue of the rat.  We hypothesize 
that IUGR will affect mRNA and protein levels of Setd8 in a gender and depot 
specific manner in VAT, SAT and hepatic tissue reflecting the previously observed 
changes in PPARγ before the onset of metabolic disease in postnatal day 21 rats.   
 
  
MATERIALS AND METHODS 
Model 
All procedures were approved by the University of Utah Animal Care Committee 
are in accordance with the American Physiological Society’s guiding principles (22).  A 
more detailed procedure has been described previously (23).  To briefly describe, on day 
19 of gestation (term is 21.5 days), the maternal Sprague-Dawley rats were anesthetized 
with intraperitoneal xylazine (8 mg/kg) and ketamine (40 mg/kg), and both inferior 
uterine arteries were ligated (IUGR).  Control dams underwent identical anesthetic 
procedures.  The blood flow to the fetus was not ablated, but reduced to a similar degree 
as that is observed in human pregnancies complicated by UPI (8).  The Lane Lab has 
extensive experience with the IUGR model, and has characterized the IUGR phenotype 
and gained mechanistic insights into the molecular and cellular response to the IUGR 
insult.  Bilateral uterine artery ligation at gestational age 19 days (term is 21.5 days) 
results in asymmetric growth restricted pups that are approximately 25% smaller than the 
control animals at birth as well as at postnatal day 21 (24).   
Maternal rats had ad libitum access to food and water and were allowed to deliver 
spontaneously at term approximately 2.5 days after the bilatereal uterine ligation.  Litters 
were culled to 6 pups, 3 male and 3 female.  The pups remained with their mothers, 
feeding via lactation, until day 21 of postnatal life.  Juvenile and adult rats underwent 
euthanasia using a sodium pentobarbital overdose (150 mg/kg).  Adipose tissue from 
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subcutaneous and retroperitoneal (visceral) depots was immediately harvested and flash 
frozen in liquid nitrogen and stored in -80°C.  The same procedure was used for liver 
tissue. For each experiment, each group (control and IUGR) had 6 male pups and 6 
female pups, unless otherwise noted.  Pups within each group were derived from different  
litters.   
Real-Time RT PCR 
Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to 
evaluate mRNA abundance in visceral, subcutaneous and liver tissues of Setd8 with 
GAPDH as an internal control.  Total mRNA for IUGR and control was extracted from 
tissue crushed in liquid nitrogen and frozen at -80°C.  RNeasy Lipid Tissue Kit (Qiagen, 
DB Bioscences CA) was used according to manufactures instruction.  mRNA was 
quantified using a Nano Drop 3300 Flourospectometer and cDNA was synthesized using 
a High Capacity cDNA reverse Transcription Kit (Applied Biosystems, Foster CA).  The 
following Assay-on-demand primer/probe set was used:  Setd8 - Rn01477383_g1 
(Applied Biosystems, Foster CA). GAPDH primer and probe sequences; Forward: 
CAAGATGGTGAAGGTCGGTGT; Reverse: CAAGAGAAGGCAGCCCTGGT; Probe: 
GCGTCCGATACGGCCAAATCCG. mRNA abundance was determined using the 
comparative Ct method with GAPDH as an internal control.  All real-time PCR 
amplification, data acquisition and analysis were done using the 7900HT Real-time PCR 
system and SDS Enterprise Software (Applied Biosystems) using a 384-Well Optical 
Reaction Plate (Applied Biosystems) at the University of Utah genomics core facility.  
Taqman Universal PCR Mastermix (Applied Biosystems) was used in a 5µL reaction, 
performed in quadruplicate.  Cycle parameters were 50°C x 2 minutes, 95°C x 10  
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minutes, followed by 40 cycles of 95°C x 15 seconds and 60°C x 60 seconds. 
Protein Analysis 
Western blotting was used to determine relative abundance of Setd8 proteins in 
SAT, VAT and liver tissue of IUGR compared to the control rats.  Day 21 adipose tissue 
was crushed in liquid nitrogen using liquid nitrogen cooled mortar and pestle.  RIPA 
buffer solution containing EDTA-free protease inhibitor tablets (Roch, Mannheim, 
Germany) was used to lyse the cells and extract total protein.  The samples were vortexed 
thoroughly and placed on ice for 10 minutes. They were rotated for 60 minutes and 
centrifuged for 20 minutes at 4°C.  Protein solution was isolated and stored in -20°C.  A 
bicinchoninic acid protein assay (BCA) kit (Pierce, Rockford, IL) utilizing a 96-well 
plate was used to quantify the protein sample solutions. Identical procedures were 
followed for liver tissue with the following exceptions: 30-minute incubation time on ice 
in place of 10 minutes and a Fisher homogenizer was used to homogenize each sample 
for 30 seconds instead of using a rotator for 60 minutes.   
Standard western blotting procedures were used with the following specifics.  For 
adipose tissue, gel samples containing equal amounts of total protein (80µg) were 
prepared from the isolated adipose protein solution and run on a 4-12% bis-tris XT 
Criterion gels (Bio-Rad Laboratories, Hercules, CA) in MOPS buffer at 150V for 60 
minutes.  Proteins were transferred to PVDF membranes in transfer buffer at 100V for 60 
minutes.  Membranes were blocked in 5% milk TBS-T for 60 minutes at room 
temperature, and next incubated overnight with the primary antibody Setd8 (Q-18) sc: 
54998 (Santa Cruz Biotechnology, Santa Cruz, CA) in 5% milk TBS-T at a concentration 
of 0.7µg/ml.  After washing, they were incubated for an hour with a donkey anti-goat 
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secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) in 5% milk TBS-T. 
Membranes were washed again and exposed with enhanced chemiluminescence (ECL) 
according to the manufacturer’s instructions (Amersham, Little Chalfont, UK) for 20 
minutes to detect the signal.  
After washing, membranes were stored overnight at 4°C.  The next morning, prior 
to incubation with GAPDH in 5% milk TBS-T for 60 minutes at room temperature at a 
concentration of 0.1µg/ml the membranes were blocked a second time for 60 minutes in 
5% milk TBS-T.  Membranes were washed, incubated in anti-rabbit secondary antibody 
with 5% milk TBS-T for 60 minutes and exposed a second time according to specifics 
mentioned above.  Identical procedures were followed for liver tissue samples with the 
following exceptions gel samples of 60µg total protein were used in place of 80µg and  
the membranes were blocked in 5% milk TBS-T overnight as opposed to 1 hour.   
Statistics 
Data are presented as means ± SEM.  IUGR data were compared to control data 
that was normalized to 100%.  Statistical significance between control and IUGR was 
determined using ANOVA.  Statistical significance was defined as a P value ≤ 0.05.    
  
RESULTS 
IUGR Increases Setd8 Protein in VAT of Male Rats 
Real-time RT-PCR was used to determine the abundance of Setd8 mRNA in VAT 
of IUGR versus control rats at day 21. IUGR did not have an effect on Setd8 mRNA 
abundance in VAT depots of male relative to the control  (125±11% P>0.05).  Also no 
significant differences were detected in mRNA abundance in VAT depots of IUGR 
females when compared to the control (85±6% P>0.05).  See Figure 1. 
Western blotting was used to determine the relative abundance of Sed8 protein in 
VAT of male and female IUGR versus control rats at day 21.  IUGR increased Setd8 
protein abundance in males relative to the controls (273±63% P<0.05). IUGR did not 
have a significant effect on Setd8 protein abundance of female relative to the controls  
(89±6% P>0.05).  See Figure 2.   
IUGR Has No Effect on Setd8 in SAT 
Real-time RT-PCR was used to determine the relative abundance of Setd8 mRNA 
in SAT of male and female IUGR versus control rats at day 21. IUGR did not have an 
effect on Setd8 mRNA abundance in SAT depots of male relative to the control (115±7% 
P>0.05).  Also no statistically significant differences were detected in mRNA abundance 
in SAT depots of IUGR females when compared to the control (90±9% P>0.05).  See 
Figure 3.  
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Western blotting was used to determine the relative abundance of Sed8 protein in 
SAT tissue of male and female IUGR versus control rats at day 21.  IUGR did not have 
an effect on Setd8 protein abundance in male relative to the controls (120±30% P>0.05). 
Also, IUGR did not have a significant effect on Setd8 protein abundance of female  
relative to the controls (102±23% P>0.05).  See Figure 4.   
IUGR Decreases Setd8 Protein in Liver of Female Rats 
Real-time RT-PCR was used to determine the relative abundance of Setd8 mRNA 
in liver tissue of IUGR versus control rats at day 21.  IUGR did not have an effect on 
Setd8 mRNA abundance in liver depots of male relative to the control (97±7% P>0.05).  
Also no statistically significant differences were detected in mRNA abundance in the 
liver of IUGR females when compared to the control (80±2% P>0.05).  See Figure 5. 
Western blotting was used to determine the relative abundance of Sed8 protein in 
liver tissue of male and female IUGR versus control rats at day 21. IUGR did not have a 
significant effect on Setd8 protein abundance in the liver of male relative to the controls 
(113±13% P>0.05).  IUGR decreased Setd8 protein abundance in the liver of female  
relative to the controls (81±6% P<0.05). See Figure 6.  
Gender Does Not Have an Effect on Setd8 mRNA 
Real-time RT-PCR was used to determine the relative abundance of Setd8 mRNA 
in SAT, VAT and liver tissue of male control versus female control rats at day 21.  There 
was no effect on Setd8 mRNA abundance in the SAT, VAT and liver tissue of male 
relative to the female.  See Figure 7.  
  
 
Figure 1.  IUGR does not affect
mRNA levels of Setd8 expressed as a percent control. 
and black solid bars represent the controls. 










































 Setd8 mRNA abundance in VAT.  The graph shows 
 White solid bars represent IUGR 
 The dashed line represents control 








Figure 2.  IUGR increases Setd8 protein abundance in
protein levels of Setd8 expressed as a percent control.
and black solid bars represent the controls.
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Figure 3.  IUGR does not affect S
mRNA levels of Setd8 expressed as a percent control. 
and black solid bars represent the controls.
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Figure 4.  IUGR does not affect Set
protein levels of Setd8 expressed as a percent control. 
and black solid bars represent the controls.










































d8 protein abundance in the SAT.  The graph shows 
 White solid bars represent IUGR 
  The dashed line represents control 








Figure 5.  IUGR does not affect Set
mRNA levels of Setd8 expressed as a percent control. 
and black solid bars represent the control.
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Figure 6.  IUGR decreases Setd8 protein abundance in 
protein levels of Setd8 expressed as a percent control.
and black solid bars represent the controls.
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  White solid bars represent IUGR 
  The dashed line represents control 












Figure 7.  Gender does not affect Setd8 mRNA abundance in VAT, SAT or liver.  The 
graph shows Detla CT values.  White solid bars represent male and black solid bars 
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In this study we provide evidence that IUGR affects the expression of Setd8 in a 
gender and depot specific manner in VAT, SAT and hepatic tissue before the onset of 
obesity in postnatal day 21 rats.  Evidence that IUGR affects expression of Setd8 in a 
gender and depot specific manner was demonstrated in VAT where IUGR increased the 
expression of Setd8 protein in male rat, and in liver where IUGR decreased the 
expression of Setd8 protein in females rat.  Together these data suggest that Setd8 
expression in IUGR is associated with the previously observed changes in PPARγ 
expression.   
PPARγ regulation of the methyltransferase Setd8 has been recently documented 
(15) suggesting PPARγ’s role in adipose and liver tissue has an epigenetic component.  
Epigenetic gene regulation refers to heritable changes in gene expression potential that 
are not caused by changes in DNA (25).  One mechanism that contributes to epigenetic 
gene regulation is the methylation of histone tails.  Setd8 puts a methyl mark in H4K20, 
which in turn increases the mark on genes, strongly correlating with an increase in gene 
expression.  This IUGR-induced increase in Setd8 protein abundance in the VAT depots, 
and its association to increased levels of mRNA and protein of PPARγ, suggest a strong 
relationship to adipose tissue dysreguation in the male neonatal rat.  Alternatively, in the 
liver of IUGR female rat the association of PPARγ and Setd8 decrease in protein 
expression may suggest that females are not as severely affected as males.  
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H4K20me1 at the exon 4 of the PPARγ gene during differentiation may determine 
PPARγ and other target gene expression.  During differentiation PPARγ up regulates the 
expression of Setd8.  Setd8 increases transcription of the PPARγ gene and its targets 
through H4K20me1. Further PPARγ binds to the PPARy2 promoter, inducing histone 
modification and ultimately increasing its transcription.  Given our results, we can 
speculate that H4K20me1 is increased in the VAT of male IUGR and decreased in the 
liver tissue of female IUGR.  This suggests that IUGR affects Setd8 and its targets in 
gender and tissue specific manner.   
IUGR leads to adipose dysfunction, which favors the accumulation of VAT in 
conjunction with an increased expression of PPARγ before the onset of obesity (12).  
PPARγ can also influence adipose glucose uptake.  PPARγ and retinoid x receptor (RXR) 
heterodimer repress transcriptional activity of the insulin responsive glucose transporter 4  
(GLUT4) via direct and specific binding on its promoter (26).  This transcriptional 
repression of GLUT4 is released via ligand binding on the PPARγ domain.  In a recent 
study it has been observed that day 21 IUGR male rats have decreased insulin sensitive 
GLUT4 mRNA in VAT (12).  We can also speculate that DHA supplementation of 
maternal diet may ameliorate adipose tissue regulation effecting PPARγ, Setd8, and 
H4K20me1 levels of Setd8 and its targets.  This benefit of a DHA maternal diet has 
already been shown in the IUGR lung (27). It is possible that the feedback mechanism 
that links PPARγ transcription and epigenetic gene regulation through Setd8 H4K20me1 
may provide a link into the IUGR, and its effect on insulin resistance.   
In conclusion we have demonstrated in a rat IUGR model that Setd8 expression 
varies in SAT, VAT and hepatic tissue in a gender and depot specific manner.  PPARγ and 
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its target histone modifying enzyme Setd8 expression seem to be strongly related to 
H4K20me1 levels on the PPARγ gene.  Further H4K20me1 modifications on Setd8 
targets in a genders and tissue specific manner suggests IUGR alters epigenetic gene 
regulation,  
and ultimately the phenotype before the adult onset of metabolic disease and obesity.   
Potential Impact 
The importance of intrauterine environment for lifelong health and disease has been 
studied extensively.  The adaption of the fetus to IUGR leads to permanent changes in 
metabolism, body composition and growth.  The adjustment to a poor and stressful 
intrauterine environment has a programming effect on lipid and glucose metabolism and 
chronic disease risk.  The IUGR infants have physiologically impaired adipose tissue 
regulation, which in adulthood is accompanied by adult onset metabolic disease, insulin 
resistance, poor fatty acid utilization, hepatic steatosis and obesity.  Given the prevalence 
and impact of such diseases in developed nations we aimed to shed some light in problem 
and looked at novel epigenetic mechanisms.  This research project provides the first in vivo 
comprehensive characterization in adipose and liver tissue of how IUGR affects the 
production of the chromatin modifying enzyme Setd8 in a gender and tissue specific 
manner.  This is important because it allows us to get a step closer to the development of  
interventions that may improve the IUGR phenotype.  
Strength and Limitations 
In order to establish the effect of the perinatal environment on the epigenetic 
modulation of transcription an in vivo model is necessary.  The IUGR model provides us 
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with the best current system of understanding on how epigenetics modulates gene 
transcription in vivo.  However, this model may not be an exact representative of the 
human condition.  Our study describes how IUGR effects Setd8 in a gender and tissue 
specific manner, however more studies are needed to explore the mechanism by which 
these specificity is attained.  For this study we looked at only one age, but the gender 
differences may be more prominent as the animals develop.  
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